Immunophenotypic profile and clinical characteristics in patients with advanced stage mantle cell lymphoma

Medical Oncology

Volumn 24, Issue 4, 2007, Pages 413-418

  Todorovic, M ^a   Pavlovic, M ^b   Balint, B ^c   Kraguljac, N ^a   Mihaljevic, B ^a   Bogdanovic, A ^a   Elezovic, I ^a   Boskovic, D ^a   Colovic, M ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b FLORIDA ATLANTIC UNIVERSITY   (United States)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Clinical characteristics; Immunophenotype; Mantle cell lymphoma

Indexed keywords

CD19 ANTIGEN; CD2 ANTIGEN; CD22 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; CD79B ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; CYCLOPHOSPHAMIDE; DOXORUBICIN; HLA A ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; PREDNISONE; VINCRISTINE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MALE; MANTLE CELL LYMPHOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, SURFACE; BONE MARROW CELLS; FEMALE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 36348935032     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-007-0029-5     Document Type: Article

References (23)

1. Harris NL, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
2. Raffeld M, Jaffe ES. Bcl-1, t (11; 14), and mantle cell-derived lymphomas. Blood 1991;78:259-63.
3. Cordell JL, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatese (APAAP-complexes). J Histoch Cytochem 1984;32:219-29.
4. Wohlschlaeger CH, Lange HM, Feller AC. Aberrant immunophenotypes of mantle cell lymphomas. Leuk Lymphoma 2003;44:269-73.
5. Matutes E, et al. The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients. Leuk Lymphoma 2004;45:2007-15.
6. Weisenburger DD, Armitage JO. Mantle cell lymphoma; an entity comes of age. Blood 1996;87:4483-94.
7. Donfrid-Todorovic M, et al. Monocytoid B cell lymphoma associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Acta Haematol 2001;106:130-2.
8. Rodig SJ, et al. Mantle cell lymphoma arising within primary nodal marginal zone lymphoma: a unique presentation of two uncommon B-cell lymphoproliferative disorders. Cancer Genet Cytogenet 2006;171:44-51.
9. Pittaluga S, et al. Prognostic significance of bone marrow trephine biopsy and peripheral blood smears in 55 patients with mantle cell lymphoma. Leuk Lymphoma 1996;21:115-25.
10. Samaha H, et al. Mantle cell lymphoma: a retrospective study of 121 cases. Leukemia 1998;12:1281-7.
11. Bosch F, et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer 1998;82:567-75.
12. Cohen PL, Kurtin PJ, Donovan KA, Hanson CA. Bone marrow and peripheral blood involvement in mantle cell lymphoma. Br J Haematol 1998;101:302-10.
13. Chuang SS, et al. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2. Pathol Int 2006;56:440-8.
14. Zhang L, Kern WF, Yu Z, Mulvihill JJ. Li. Cryptic and complex chromosomal rearrangements and the deletion of TP53. Cancer Genet Cytogenet 2006;169:169-73.
15. Yin CC, et al. Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma. Mod Pathol 2007;20:1-7.
16. Parrens M, et al. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features. Histopathology 2006;48:353-62.
17. Sarfati M, Fournier S, Wu CY, Delespesse G. Expression, regulation and function of human Fc epsilon RII (CD23) antigen. Immunol Res 1992;11:260-72.
18. Prinz JC, Baur X, Mazur G, Rieber EP. Allergen-directed expression of Fc receptors for IgE (CD23) on human T lymphocytes is modulated by interleukin 4 and interferon-gamma. Eur J Immuno 1990;20:1259-64.
19. Reljic R, Cosentino G, Gould HJ. Function of CD23 in the response of human B cells to antigen. Eur J Immunol 1997;27:572-5.
20. Lai R, et al. Immunoglobulin VH somatic hypermutation in mantle cell lymphoma: mutated. Mod Pathol 2006;19:1498-05.
21. Salar A, et al. Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study. Am J Surg Pathol 2006;30:1274-80.
22. Nickenig C, et al. German Low-Grade Lymphoma Study Group. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group. Cancer 2006;107:1014-22.
23. Ritchie DS, et al. The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma. Ann Hematol 2007;86:101-5.